Ampyra (Dalfampridine) Tablet, 10MG


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 38.9%
Gait Disturbance 26.7%
Multiple Sclerosis 24.3%
Drug Use For Unknown Indication 5.2%
Urinary Tract Infection 0.7%
Balance Disorder 0.5%
Muscular Weakness 0.5%
Relapsing-remitting Multiple Sclerosis 0.5%
Twitching Of Limbs 0.2%
Arthralgia 0.2%
Depression 0.2%
Fatigue 0.2%
Foetal Exposure During Pregnancy 0.2%
Mobility Decreased 0.2%
Motor Dysfunction 0.2%
Ms 0.2%
Multiple Sclerosis Flare 0.2%
Neuralgia 0.2%
Tremor 0.2%
Walking Difficulty 0.2%
Death 14.5%
Convulsion 13.9%
Urinary Tract Infection 13.9%
Multiple Sclerosis Relapse 5.5%
Vomiting 5.5%
Myocardial Infarction 4.8%
Tremor 4.8%
Fall 4.2%
Hip Fracture 3.0%
Inappropriate Schedule Of Drug Administration 3.0%
Movement Disorder 3.0%
Urinary Retention 3.0%
Weight Decreased 3.0%
Wheelchair User 3.0%
Drug Ineffective 2.4%
Memory Impairment 2.4%
Muscular Weakness 2.4%
Pain 2.4%
Pneumonia 2.4%
Sepsis 2.4%

Drug Data